Amidst the dynamic landscape of pharma - covigilance legislation, medical writers have been gaining increased visibility and importance beyond what had been their traditional role of coordinating and facil it - ating the development of risk management plans. Over the past couple of years, medical writers have been contributing extensively in driving the seamless integration of the recent Good Pharmacovigilance Practices guidance version 2.0 into companies’ global pharma - covigilance systems, quality assurance systems, and relevant standard operating procedures. A comprehensive “360°” approach adapted by medical writers ensures efficient authoring of high-quality RMPs.